Omega-3 Fatty Acid Composition for PPARα Receptor Activation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current omega-3 fatty acid nutraceutical formulations are not optimized to deliver the highest effective concentration of omega-3 agonists to health-promoting targets like PPARα receptors, and they do not fully replicate the beneficial effects of caloric restriction, which are essential for improved health outcomes.

Innovation Solution

A novel omega-3 fatty acid composition that combines phospholipid and free fatty acid forms to enhance membrane fluidity and receptor activation, specifically targeting PPARα receptors, thereby mimicking the effects of caloric restriction and improving health outcomes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If conventional omega-3 formulations are used, then basic nutritional supplementation is provided, but the effective concentration of omega-3 agonists at health-promoting targets is insufficient

Engineering Contradiction:
Improveeffective concentration of omega-3 agonistsVSAvoidhealth outcome effectiveness
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent applies parameter changes by modifying the chemical form and physical state of omega-3 fatty acids. It uses highly concentrated omega-3 fatty acids in specific ester forms (ethyl ester, monoglyceride, diglyceride, triglyceride) with concentrations of at least 80%, 85%, 90%, or 95% purity. This parameter optimization ensures sufficient dosage while maintaining stability and bioavailability, resolving the contradiction between quantity and reliability of health effects.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs composite materials by combining omega-3 fatty acids with specific carrier substances and excipients. The formulation includes omega-3 fatty acids in combination with antioxidants (vitamin E, vitamin C), anti-inflammatory agents (curcumin, resveratrol), and various carriers (oils, fats, waxes). This composite approach enhances the stability, bioavailability, and therapeutic effectiveness of omega-3 agonists, addressing both concentration and reliability requirements.

Inventive Principle:
Principle #40Composite materials

2Object-affected harmful factors

If molecular distillation is used to purify omega-3 fatty acids, then unwanted impurities are removed, but the complexity of the manufacturing process increases

Engineering Contradiction:
Improveunwanted impuritiesVSAvoidmanufacturing process complexity
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The patent applies the extraction principle by using molecular distillation to selectively separate and remove unwanted impurities from omega-3 fatty acid sources. The process extracts heavy metals, dioxins, PCBs, and other contaminants while concentrating the desired omega-3 fatty acids to high purity levels (80-95%). This extraction approach effectively eliminates harmful factors while maintaining a relatively streamlined manufacturing process.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent utilizes parameter changes in the molecular distillation process by controlling temperature, pressure, and residence time parameters. The process operates at reduced pressures and elevated temperatures to achieve selective vaporization and separation of impurities from omega-3 fatty acids. By optimizing these parameters, the patent achieves high purification efficiency without requiring excessively complex manufacturing equipment or multi-step processes.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If high concentrations of omega-3 fatty acids are used, then health-promoting effects are enhanced, but the cost of the nutraceutical composition increases

Engineering Contradiction:
Improvehealth outcome effectivenessVSAvoidmanufacturing cost
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent applies parameter changes by optimizing the concentration levels of omega-3 fatty acids to achieve therapeutic effectiveness at manageable cost levels. The formulation specifies omega-3 fatty acid concentrations of at least 80%, 85%, 90%, or 95% purity, with each level representing a balance between health effectiveness and manufacturing cost. This parameter optimization allows producers to select appropriate concentration levels based on market requirements and cost considerations.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs multi-functionality by using omega-3 fatty acids that serve multiple purposes: they act as the primary active ingredient providing health benefits, serve as the base material for further chemical modifications (esterification to different forms), and function as a platform for combining with various co-ingredients (antioxidants, anti-inflammatory agents). This multi-functional approach maximizes the value derived from the omega-3 fatty acid input, improving cost-effectiveness while maintaining high health outcome reliability.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The combination of phospholipid and free fatty acid forms of omega-3 fatty acids in the novel composition synergistically enhances membrane fluidity and receptor activation, leading to improved health effects such as increased PPARα receptor activation, better fat metabolism, and potential benefits associated with caloric restriction, including reduced triglycerides and improved glucose control.

Implementation Method 1

the phospholipid form of omega-3 fatty acids are better at enhancing membrane fluidity and permeability

Methodology Applied
Scientific EffectMembrane fluidity enhancement:

Implementation Method 2

other forms of omega-3 fatty acids (e.g. free fatty acid forms) are better at stimulating biological receptors of interest, such as the PPARα receptors

Methodology Applied
Scientific EffectReceptor activation:

Data Source

PatentUS11266665B1Omega-3 fatty acid nutriceutical compositions and methods
Publication Date: 2022.03.08 ROSEDALE RONALD E
  • US11266665B1 patent drawing
  • US11266665B1 patent drawing

AI summary

A novel omega-3 fatty acid/lipid-based nutraceutical composition and a method of optimizing said omega-3 fatty acid/lipid-based nutraceutical composition. The nutraceutical composition and method is based on the insight that different forms of high omega-3 fatty acid lipids (e.g. triglyceride form, ethyl ester form, free fatty acid form, phospholipid form) have different molecular modes and levels of action. Specifically, the phospholipid form is likely more effective at promoting membrane fluidity and permeability, while the free fatty acid form is likely more effective at regulating cell receptors, such as the PPARa receptors, that are responsible for various metabolic effects including lipid metabolism. The desirability of producing omega-3 compositions that may act synergistically and thus more robustly to improve health and to some extent mimic markers of life extension such as shown by caloric restriction, along with specific optimization methods, markers, and compositions are taught.